Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

A novel angiotensin analog with subnanomolar affinity for angiotensin-converting enzyme.

Krebs LT, Hanesworth JM, Sardinia MF, Speth RC, Wright JW, Harding JW.

J Pharmacol Exp Ther. 2000 Apr;293(1):260-7.

PMID:
10734177
2.

Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs.

Krishnan R, Hanesworth JM, Wright JW, Harding JW.

Peptides. 1999;20(8):915-20.

PMID:
10503768
3.

Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning.

Wright JW, Stubley L, Pederson ES, Kramár EA, Hanesworth JM, Harding JW.

J Neurosci. 1999 May 15;19(10):3952-61.

4.

Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues.

Zhang JH, Hanesworth JM, Sardinia MF, Alt JA, Wright JW, Harding JW.

J Pharmacol Exp Ther. 1999 May;289(2):1075-83.

PMID:
10215690
5.

Sex differences in discriminative stimulus and diuretic effects of the kappa opioid agonist U69,593 in the rat.

Craft RM, Kruzich PJ, Boyer JS, Harding JW, Hanesworth JM.

Pharmacol Biochem Behav. 1998 Dec;61(4):395-403.

PMID:
9802834
6.

Characterization and purification of the bovine adrenal angiotensin IV receptor (AT4) using [125I]benzoylphenylalanine-angiotensin IV as a specific photolabel.

Zhang JH, Stobb JW, Hanesworth JM, Sardinia MF, Harding JW.

J Pharmacol Exp Ther. 1998 Oct;287(1):416-24.

PMID:
9765364
7.
8.

Solid-phase synthesis of hydroxyethylamine angiotensin analogues.

Chambers SL, Ronald R, Hanesworth JM, Kinder DH, Harding JW.

Peptides. 1997;18(4):505-12.

PMID:
9210168
9.

Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.

Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW.

Regul Pept. 1996 Dec 3;67(2):123-30.

PMID:
8958583
10.

Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells.

Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW.

Regul Pept. 1995 Aug 22;58(3):107-15.

PMID:
8577922
11.

AT4 receptors: specificity and distribution.

Harding JW, Wright JW, Swanson GN, Hanesworth JM, Krebs LT.

Kidney Int. 1994 Dec;46(6):1510-2.

12.

Noise-induced elevations of plasma endothelin (ET-3).

Quirk WS, Coleman JK, Hanesworth JM, Harding JW, Wright JW.

Hear Res. 1994 Oct;80(1):119-22.

PMID:
7852197
13.

AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues.

Sardinia MF, Hanesworth JM, Krishnan F, Harding JW.

Peptides. 1994;15(8):1399-406.

PMID:
7700843
14.

Central angiotensin IV binding sites: distribution and specificity in guinea pig brain.

Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Wright JW, Speth RC, Grove KL, Harding JW.

J Pharmacol Exp Ther. 1993 Sep;266(3):1718-26.

PMID:
8371170
15.

AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides.

Sardinia MF, Hanesworth JM, Krebs LT, Harding JW.

Peptides. 1993 Sep-Oct;14(5):949-54.

PMID:
8284271
16.

Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes.

Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW.

J Pharmacol Exp Ther. 1993 Aug;266(2):1036-42.

PMID:
8355180
17.
18.

Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory.

Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW.

Brain Res Bull. 1993;32(5):497-502.

PMID:
8221142
19.

Hypothalamic angiotensin release in response to AII or glutamic acid stimulation of the SFO in rats.

Wright JW, Roberts KA, Stubley LA, Hanesworth JM, Harding JW.

Brain Res Bull. 1993;31(6):649-54.

PMID:
8100178
20.

Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor.

Swanson GN, Hanesworth JM, Sardinia MF, Coleman JK, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, et al.

Regul Pept. 1992 Aug 13;40(3):409-19.

PMID:
1438983
21.

Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus.

Harding JW, Cook VI, Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Stobb JW, Swanson GN, Coleman JK, Wright JW, et al.

Brain Res. 1992 Jun 26;583(1-2):340-3.

PMID:
1504842
22.

Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli.

Harding JW, Jensen LL, Hanesworth JM, Roberts KA, Page TA, Wright JW.

Am J Physiol. 1992 Jan;262(1 Pt 2):F17-23.

PMID:
1733292
23.

Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels.

Batt CM, Jensen LL, Hanesworth JM, Harding JW, Wright JW.

Brain Res. 1990 Oct 8;529(1-2):126-30.

PMID:
2282487
24.

Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat.

Dewey AL, Wright JW, Hanesworth JM, Harding JW.

Brain Res. 1988 May 17;448(2):369-72.

PMID:
3378160
25.

Comparison of 125I-angiotensin III and 125I-angiotensin II binding to rat brain membranes.

Abhold RH, Hanesworth JM, Harding JW.

J Neurochem. 1988 Mar;50(3):831-8.

PMID:
3339357
26.

Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats.

Wright JW, Quirk WS, Hanesworth JM, Harding JW.

Brain Res. 1988 Feb 16;441(1-2):215-20.

PMID:
3359232
27.

Inability of [125I]Sar1, Ile8-angiotensin II to move between the blood and cerebrospinal fluid compartments.

Harding JW, Sullivan MJ, Hanesworth JM, Cushing LL, Wright JW.

J Neurochem. 1988 Feb;50(2):554-7.

PMID:
3335860
28.

Delayed cerebroventricular metabolism of [125I]angiotensins in the spontaneously hypertensive rat.

Wright JW, Sullivan MJ, Bredl CR, Hanesworth JM, Cushing LL, Harding JW.

J Neurochem. 1987 Aug;49(2):651-4.

PMID:
3598591

Supplemental Content

Loading ...
Support Center